Annexin A2, A7, and A11 expression in head and neck squamous cell carcinoma

Turkish Journal of Medical Sciences

Volumn 39, Issue 4, 2009, Pages 547-555

  Hücümenoǧlu, Sema ^a,c   Gümüşkaya, Berrak ^a   Alper, Murat ^a   Öcal, Bülent ^a   Karabulut, Erdem ^b  

^a DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Annexin A11; Annexin A2; Annexin A7; Head and neck neoplasms; Squamous cell carcinoma

Indexed keywords

ANNEXIN A11; ANNEXIN A2; ANNEXIN A7; HEAD AND NECK NEOPLASMS; SQUAMOUS CELL CARCINOMA;

CELL MEMBRANES; PARAFFIN WAXES; PARAFFINS; TUMORS;

ANTIBIOTICS;

ANNEXIN; ANNEXIN A11; LIPOCORTIN 2; SYNEXIN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; TUMOR GROWTH;

EID: 69249110536     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: 10.3906/sag-0901-1     Document Type: Article

References (23)

1. Gerke V, Creutz CE, Moss SE. Annexins: Linking Ca+2 signalling to membrane dynamics. Nat Rev Mol Cell Biol 2005; 6(6): 449-461. (Pubitemid 40780557)
2. Gerke V, Moss SE. Annexins: from structure to function. Physiol Rev 2002; 82: 331-371
3. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000; 24: 227-235. (Pubitemid 30132189)
4. Xin W, Rhodes DR, Ingold C, Chinnaiyan AM, Rubin MA. Dysregulation of the annexin family protein family is associated with prostate cancer progression. Am J Pathol 2003; 162: 255-261. (Pubitemid 36042007)
5. Hippo Y, Yashiro M, Ishii M, Taniguchi H, Tsutsumi S, Hirakawa K et al. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res 2001; 61: 889-895. (Pubitemid 32174397)
6. Wu W, Tang X, Hu W, Lotan R, Hong WK, Mao L. Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two dimensional electrophoresis and mass spectrometry. Clin Exp Metastasis 2002; 19: 319-326. (Pubitemid 34606757)
7. Hayes MJ, Longbottom RE, Evans MA, Moss SE. Annexinopathies. In: Carafoli E, Brini M, editors. Calcium Signalling and Disease. Netherlands: Springer; 2007. p.1-28.
8. Mussunoor S, Murray GI. The role of annexins in tumour development and progression. J Pathol 2008; 216(2): 131-140.
9. Emoto K, Sawada H, Yamada Y, Fujimoto H, Takahama Y, Ueno M et al. Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma. Anticancer Res 2001; 21(2B): 1339-1345. (Pubitemid 32494144)
10. Rodrigo Tapia JP, Pena Alonso E. Annexin A2 expression in head and neck squamous cell carcinoma. Acta Otorinolaringol Esp 2007; 58: 257-262. (Pubitemid 47251510)
11. Cardesa A, Gale N, Nadal A, Zidar N. Squamous cell carcinoma. In: Barnes L, Eveson W J, Reichart P, Sidransky D, editors. World Health Organization Classification of Tumours Pathology & Genetics of Head and Neck Tumours. Lyon: IARC Press; 2005. p.118-121.
12. Lin CY, Jeng YM, Chou HY, Hsu HC, Yuan RH, Chiang CP et al. Nuclear localization of annexin A1 is a prognostic factor in oral squamous cell carcinoma. J Surg Oncol 2008; 97(6): 544-550. (Pubitemid 351631436)
13. Garcia-Pedrero JM, Fernandez MP. Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. American Journal of Pathology 2004; 164: 73-79.
14. Zhi H, Zhang J, Hu G, Lu J, Wang X, Zhou C et al. The deregulation of arachidonic acid metabolism related gen in human esophageal squamous cell carcinoma. Int J Cancer 2003; 106: 327-333. (Pubitemid 36870392)
15. Srivastava M, Atwater I, Glasman M, Leighton X, Goping G, Caohuy H et al. Defects in inositol 1,4,5-triphophate receptor expression, Ca(2+) signaling, and insulin secretion in the ANXA7 (+/-) knockout mouse. Proc Natl Acad Sci USA 1999; 96: 13783-13788.
16. Srivastava M, Bubendorf L, Nolan L, Glasman M, Leighton X, Miller G et al. ANX7 as a bio-marker in prostate and breast cancer progression. Dis Markers 2001; 17: 115-120. (Pubitemid 32964843)
17. Hsu PI, Huang MS, Chen HC, Hsu PN, Lai TC, Wang JL et al. The significance of ANX A7 expression and its correlation with poor cellular differentiation and enhanced metastatic potential of gastric cancer. J Surg Oncol 2008; 97: 609-614.
18. Srivasta M, Torosyan Y, Raffeld M, Eidelman O, Pollard HB, Bubendorf L. ANXA7 expression represents hormone-relevant tumor suppression in different cancers. Int J Cancer 2007; 121: 2628-2636. (Pubitemid 350136405)
19. Tomas A, Moss SE. Calcium and cell cycle dependent association of annexin 11 with the nuclear envelope. J Biol Chem 2003; 278: 20210-20216. (Pubitemid 36799218)
20. Tomas A, Clare F, Moss SE. Annexin 11 is required for midbody formation and completion of the terminal phase of cytokinesis. J Cell Biol 2004; 165: 813-822. (Pubitemid 38821972)
21. Duncan R, Carpenter B, Main LC, Telfer CT, Murray GI. Characterisation and protein expression profiling of annexins in colorectal cancer. Br J Cancer 2008; 98: 426-433. (Pubitemid 351161239)
22. Sharma MC, Sharma M. The role of annexin 2 in angiogenesis and tumor progression: a potential therapeutic target. Curr Pharm Des 2007; 13: 3568-3575. (Pubitemid 350238927)
23. Oh P, Li Y, Yu J, Durr E, Krasinska KM, Carver LA et al. Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature 2004; 429: 629-635. (Pubitemid 38812308)